Insider · CIK 0002017423
Kaitlin M. Kestenberg-Messina
Files at ADMA (ADMA BIOLOGICS, INC.). First filing Mar 10, 2026, latest Mar 10, 2026.
In brief
Kaitlin M. Kestenberg-Messina files SEC Form 4 as COO at ADMA (ADMA BIOLOGICS, INC.). Since Mar 10, 2026, Kaitlin M. Kestenberg-Messina has reported 0 open-market buys worth $0 and 1 open-market sell worth $158k, the latest filed on Mar 10, 2026.
A track record needs three past buys with six months of prices behind them; Kaitlin M. Kestenberg-Messina has 0, so none is measured yet.
The newest scored trade: sold $158k of ADMA on Mar 9, 2026, filed Mar 10, 2026, scored 24 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $158k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ADMA: ADMA BIOLOGICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 24Weak | ADMA BIOLOGICS, INC. | $158k 10,096 shares | -2% | +13% from low-36% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 9, 2026 | ADMA ADMA BIOLOGICS, INC. | 10,096 0.00% of outstanding | $155k | Mar 9, 2026 | none |
Transactions
Every row this insider has filed, 33 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 24, 2026 | ADMA ADMA BIOLOGICS, INC. | FTax withholding Common Stock | -3,177 | $8.37 | $27k | 443,061 | Jul 28, 2026 |
| Apr 1, 2026 | ADMA ADMA BIOLOGICS, INC. | FTax withholding Common Stock | -20,362 | $9.11 | $185k | 446,238 | Apr 3, 2026 |
| Mar 6, 2026 | ADMA ADMA BIOLOGICS, INC. | FTax withholding Common Stock | -10,059 | $15.39 | $155k | 562,101 | Mar 10, 2026 |
| Mar 7, 2026 | ADMA ADMA BIOLOGICS, INC. | FTax withholding Common Stock | -4,235 | $15.39 | $65k | 557,866 | Mar 10, 2026 |
| Mar 9, 2026 | ADMA ADMA BIOLOGICS, INC. | JOther Common Stock | -91,266 | $0.00 | $0 | 466,600 | Mar 10, 2026 |
| Mar 9, 2026 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +2,500 | $5.00 | $13k | 469,100 | Mar 10, 2026 |
| Mar 9, 2026 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +1,250 | $4.31 | $5,388 | 470,350 | Mar 10, 2026 |
| Mar 9, 2026 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +2,646 | $2.83 | $7,488 | 472,996 | Mar 10, 2026 |
| Mar 9, 2026 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +1,525 | $2.35 | $3,584 | 474,521 | Mar 10, 2026 |
| Mar 9, 2026 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +2,175 | $1.55 | $3,371 | 476,696 | Mar 10, 2026 |
| Mar 9, 2026 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock | -10,096 | $15.63 | $158k | 466,600 | Mar 10, 2026 |
| Mar 9, 2026 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (right to buy)derivative | -2,500 | $0.00 | $0 | 2,500 | Mar 10, 2026 |
| Mar 9, 2026 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (right to buy)derivative | -1,250 | $0.00 | $0 | 1,250 | Mar 10, 2026 |
| Mar 9, 2026 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (right to buy)derivative | -2,646 | $0.00 | $0 | 2,771 | Mar 10, 2026 |
| Mar 9, 2026 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (right to buy)derivative | -1,525 | $0.00 | $0 | 2,225 | Mar 10, 2026 |
| Mar 9, 2026 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (right to buy)derivative | -2,175 | $0.00 | $0 | 2,825 | Mar 10, 2026 |
| Feb 19, 2026 | ADMA ADMA BIOLOGICS, INC. | FTax withholding Common Stock | -8,161 | $16.32 | $133k | 572,160 | Feb 23, 2026 |
| Feb 9, 2026 | ADMA ADMA BIOLOGICS, INC. | AGrant or award Common Stock | +91,631 | $0.00 | $0 | 580,321 | Feb 11, 2026 |
| Feb 9, 2026 | ADMA ADMA BIOLOGICS, INC. | AGrant or award Stock Option (right to buy)derivative | +144,230 | $0.00 | $0 | 144,230 | Feb 11, 2026 |
| Jul 30, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +2,500 | $8.98 | $22k | 489,898 | Aug 1, 2025 |
| Jul 30, 2025 | ADMA ADMA BIOLOGICS, INC. | FTax withholding Common Stock | -1,208 | $18.59 | $22k | 488,690 | Aug 1, 2025 |
| Jul 30, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Employee Stock Option (right to buy)derivative | -2,500 | $0.00 | $0 | 0 | Aug 1, 2025 |
| Jul 24, 2025 | ADMA ADMA BIOLOGICS, INC. | FTax withholding Common Stock | -3,027 | $17.31 | $52k | 487,398 | Jul 28, 2025 |
| Apr 1, 2025 | ADMA ADMA BIOLOGICS, INC. | FTax withholding Common Stock | -18,920 | $19.42 | $367k | 490,425 | Apr 2, 2025 |
| Mar 6, 2025 | ADMA ADMA BIOLOGICS, INC. | FTax withholding Common Stock | -8,881 | $16.91 | $150k | 513,280 | Mar 10, 2025 |
| Mar 7, 2025 | ADMA ADMA BIOLOGICS, INC. | FTax withholding Common Stock | -3,935 | $17.02 | $67k | 509,345 | Mar 10, 2025 |
| Feb 25, 2025 | ADMA ADMA BIOLOGICS, INC. | FTax withholding Common Stock | -1,855 | $15.44 | $29k | 522,161 | Feb 27, 2025 |
| Feb 19, 2025 | ADMA ADMA BIOLOGICS, INC. | AGrant or award Common Stock | +77,784 | $0.00 | $0 | 524,016 | Feb 21, 2025 |
| Feb 19, 2025 | ADMA ADMA BIOLOGICS, INC. | AGrant or award Stock Option (right to buy)derivative | +116,279 | $0.00 | $0 | 116,279 | Feb 21, 2025 |
| Jan 30, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +5,000 | $10.80 | $54k | 449,587 | Feb 3, 2025 |
| Jan 30, 2025 | ADMA ADMA BIOLOGICS, INC. | FTax withholding Common Stock | -3,355 | $16.10 | $54k | 446,232 | Feb 3, 2025 |
| Jan 30, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Employee Stock Option (right to buy)derivative | -5,000 | $0.00 | $0 | 0 | Feb 3, 2025 |
| Dec 31, 2024 | ADMA ADMA BIOLOGICS, INC. | FTax withholding Common Stock | -1,854 | $17.15 | $32k | 444,587 | Jan 3, 2025 |
Questions about Kaitlin M. Kestenberg-Messina
Answered from the filings on this page, as of the latest one.
Is Kaitlin M. Kestenberg-Messina buying or selling?
In the last 12 months Kaitlin M. Kestenberg-Messina reported 0 open-market buys worth $0 and 1 open-market sell worth $158k on SEC Form 4; the latest was sold $158k of ADMA on Mar 9, 2026. Grants, option exercises and tax withholding are not counted.
How did Kaitlin M. Kestenberg-Messina's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kaitlin M. Kestenberg-Messina has 0.
Where does Kaitlin M. Kestenberg-Messina file Form 4?
Kaitlin M. Kestenberg-Messina has filed Form 4 at ADMA (ADMA BIOLOGICS, INC.) as COO and SVP, Compliance. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.